Search research articles
Contact Us
Filters
Showing results (821-830 of 1,264) with videos related to
Page
of 127
Sort By:
Ethnicity & Disease
|
December 1, 2005
Oral health disparities and periodontal disease in Asian and Pacific Island populations
Rosanne C Harrigan, David Easa, Claude LeSaux, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1983
Pharmacokinetic quantitation of naltrexone controlled release from a copolymer delivery system
R H Reuning, S H Liao, A E Staubus, et al.
Journal of Clinical Microbiology
|
April 19, 2013
Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch collaborative study
Elise Tu, Luke C Swenson, Sally Land, et al.
Current Therapeutic Research, Clinical and Experimental
|
September 23, 2020
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers
Marie A Printz, Samuel S Dychter, Emanuel P DeNoia, et al.
Clinical Therapeutics
|
February 4, 2014
Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers
Samuel S Dychter, Rena Harrigan, Jesse D Bahn, et al.
Research Square
|
July 28, 2023
Application of VirCapSeq-VERT and BacCapSeq In the Diagnosis of Presumed and Definitive Neuroinfectious Diseases
Abhilasha P Boruah, Adam Kroopnick, Riddhi Thakkar, et al.
Journal of Neurovirology
|
October 18, 2023
Application of VirCapSeq-VERT and BacCapSeq in the diagnosis of presumed and definitive neuroinfectious diseases
Abhilasha P Boruah, Adam Kroopnick, Riddhi Thakkar, et al.
AIDS Care
|
January 11, 2011
Suboptimal use of HIV drug resistance testing in a universal health-care setting
O Eyawo, K A Fernandes, E K Brandson, et al.
The Journal of Infectious Diseases
|
March 19, 2005
HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach
P Richard Harrigan, Brian Wynhoven, Zabrina L Brumme, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 11, 2008
The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes
Lily W Y Tam, Celia K S Chui, Chanson J Brumme, et al.
Page
of 127
Search research articles
Search
Showing results (821-830 of 1,264) with videos related to
Sort By:
Page
of 127
Ethnicity & Disease
|
December 1, 2005
Oral health disparities and periodontal disease in Asian and Pacific Island populations
Rosanne C Harrigan, David Easa, Claude LeSaux, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1983
Pharmacokinetic quantitation of naltrexone controlled release from a copolymer delivery system
R H Reuning, S H Liao, A E Staubus, et al.
Journal of Clinical Microbiology
|
April 19, 2013
Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc Switch collaborative study
Elise Tu, Luke C Swenson, Sally Land, et al.
Current Therapeutic Research, Clinical and Experimental
|
September 23, 2020
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers
Marie A Printz, Samuel S Dychter, Emanuel P DeNoia, et al.
Clinical Therapeutics
|
February 4, 2014
Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers
Samuel S Dychter, Rena Harrigan, Jesse D Bahn, et al.
Research Square
|
July 28, 2023
Application of VirCapSeq-VERT and BacCapSeq In the Diagnosis of Presumed and Definitive Neuroinfectious Diseases
Abhilasha P Boruah, Adam Kroopnick, Riddhi Thakkar, et al.
Journal of Neurovirology
|
October 18, 2023
Application of VirCapSeq-VERT and BacCapSeq in the diagnosis of presumed and definitive neuroinfectious diseases
Abhilasha P Boruah, Adam Kroopnick, Riddhi Thakkar, et al.
AIDS Care
|
January 11, 2011
Suboptimal use of HIV drug resistance testing in a universal health-care setting
O Eyawo, K A Fernandes, E K Brandson, et al.
The Journal of Infectious Diseases
|
March 19, 2005
HIV-1 drug resistance: degree of underestimation by a cross-sectional versus a longitudinal testing approach
P Richard Harrigan, Brian Wynhoven, Zabrina L Brumme, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
October 11, 2008
The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes
Lily W Y Tam, Celia K S Chui, Chanson J Brumme, et al.
Page
of 127